Endometriosis and Ovarian Cancer: A Genetic Connection
Oct 23, 2024New Study Links Endometriosis to Increased Ovarian Cancer Risk
Key Points
Lay Summary
Academicians Zhang and Yan from Ningbo University, Zhejiang, China, have recently published a pivotal study in Scientific Reports examining the cancer risk associated with endometriosis.
Endometriosis, a chronic condition affecting approximately 6–10% of women worldwide, significantly diminishes quality of life through a range of debilitating symptoms. Alarmingly, individuals with endometriosis also appear to face an elevated risk of developing cancer. While several observational studies have addressed the potential malignancy risk linked to endometriosis, the precise impact of this condition on cancer development remains elusive.
The current study employs a robust two-sample Mendelian randomization analysis to investigate the genetically determined relationship between endometriosis and neoplastic transformation. This analysis utilized inverse variance weighting, MR Egger regression, and weighted median methods, drawing on publicly available genome-wide association study (GWAS) summary statistics.
By incorporaing data from large-scale GWAS, encompassing 15,088 European endometriosis cases and 107,564 controls, the findings provide compelling evidence of a statistically significant association between endometriosis and the risk of ovarian cancer, as indicated by the inverse-variance weighted method. Notably, the study highlights a particularly strong statistical correlation with clear cell ovarian cancer and endometrioid ovarian cancer.
It is crucial to note that all GWAS data analyzed were derived from European populations, raising questions about the generalizability of these findings to other demographic groups. Additionally, the study underscores the need to consider potential confounding factors associated with cancer risk, which could affect the accuracy of the results.
Research Source: https://pubmed.ncbi.nlm.nih.gov/38600147/
Mendelian genetics endometriosis cancer risk ovarian cancer